Haemonetics
HAE
$89.58
Share price
-1.73%
Change (1 day)
30.66%
Change (1 year)
Categories
P/S ratio for Haemonetics (HAE)
P/S ratio as of October 2023 (TTM): 3.73
According to Haemonetics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.72807. At the end of 2023 the company had a P/S ratio of 3.54.
P/S ratio history for Haemonetics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.54 | 0.3% |
| 2022 | 3.52 | 23.95% |
| 2021 | 2.84 | -58.31% |
| 2020 | 6.82 | 17.74% |
| 2019 | 5.79 | 8.1% |
| 2018 | 5.36 | 56.98% |
| 2017 | 3.41 | 48.18% |
| 2016 | 2.30 | 25.64% |
| 2015 | 1.83 | -11.96% |
| 2014 | 2.08 | -9.73% |
| 2013 | 2.31 | -9.32% |
| 2012 | 2.54 | 18.34% |
| 2011 | 2.15 | -7.06% |
| 2010 | 2.31 | 4.99% |
| 2009 | 2.20 | -10.4% |
| 2008 | 2.46 | -24.66% |
| 2007 | 3.26 | 21.62% |
| 2006 | 2.68 | -15.47% |
| 2005 | 3.18 | 29.18% |
| 2004 | 2.46 | 43.56% |
| 2003 | 1.71 | 10.31% |
| 2002 | 1.55 | -44.95% |
| 2001 | 2.82 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.01 | 7.45% | 🇺🇸 USA |
 Medtronic MDT | 3.30 | -11.38% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 4.49 | 20.40% | 🇺🇸 USA |
 Baxter BAX | 1.27 | -65.86% | 🇺🇸 USA |
 Becton Dickinson BDX | 3.94 | 5.63% | 🇺🇸 USA |
 Stryker Corporation SYK | 5.33 | 43.09% | 🇺🇸 USA |
 PerkinElmer
PKI | 4.31 | 15.49% | 🇺🇸 USA |
 Cerus CERS | 1.91 | -48.79% | 🇺🇸 USA |